Cargando…
The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors
Essential thrombocythemia is a rare hematological malignancy with good overall survival, but moderate to high risk of developing arterial or venous thrombosis lifelong. Different thrombotic risk scores for patients with essential thrombocythemia have been proposed, but only one of them (the IPSET-t...
Autores principales: | Mancuso, Salvatrice, Accurso, Vincenzo, Santoro, Marco, Raso, Simona, Contrino, Angelo Davide, Perez, Alessandro, Di Piazza, Florinda, Florena, Ada Maria, Russo, Antonio, Siragusa, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139859/ https://www.ncbi.nlm.nih.gov/pubmed/32280344 http://dx.doi.org/10.1155/2020/9124821 |
Ejemplares similares
-
Cardiovascular Risk in Essential Thrombocythemia and Polycythemia Vera: Thrombotic Risk and Survival
por: Accurso, Vincenzo, et al.
Publicado: (2020) -
Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study
por: Accurso, Vincenzo, et al.
Publicado: (2019) -
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system
por: Accurso, Vincenzo, et al.
Publicado: (2019) -
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep
por: Accurso, Vincenzo, et al.
Publicado: (2020) -
Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia
por: Santoro, Marco, et al.
Publicado: (2022)